B. Esplin

444 total citations
27 papers, 369 citations indexed

About

B. Esplin is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, B. Esplin has authored 27 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 9 papers in Cognitive Neuroscience. Recurrent topics in B. Esplin's work include Neuroscience and Neuropharmacology Research (20 papers), Ion channel regulation and function (7 papers) and Epilepsy research and treatment (7 papers). B. Esplin is often cited by papers focused on Neuroscience and Neuropharmacology Research (20 papers), Ion channel regulation and function (7 papers) and Epilepsy research and treatment (7 papers). B. Esplin collaborates with scholars based in Canada. B. Esplin's co-authors include R. Čapek, Michael Jackson, M. Frances Davies, Patricia Boksa, H. El‐Bizri, Maryka Quik, Isabelle Chaudieu, Paul B. S. Clarke, Don W. Esplin and Gerald W. Bourne and has published in prestigious journals such as Journal of Neurophysiology, Brain Research and Neuroscience.

In The Last Decade

B. Esplin

27 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Esplin Canada 11 259 177 82 62 60 27 369
B.S.R. Sastry Canada 11 228 0.9× 174 1.0× 29 0.4× 94 1.5× 74 1.2× 14 445
Peter Dobelis United States 8 148 0.6× 188 1.1× 42 0.5× 48 0.8× 45 0.8× 8 397
Tsugutaka Ito Japan 10 202 0.8× 154 0.9× 52 0.6× 50 0.8× 76 1.3× 40 404
Sylvester E. Vizi Hungary 8 266 1.0× 176 1.0× 33 0.4× 57 0.9× 24 0.4× 16 417
Walter Schlosser United States 10 203 0.8× 94 0.5× 43 0.5× 51 0.8× 43 0.7× 13 283
Amy DiCamillo United States 8 159 0.6× 123 0.7× 42 0.5× 61 1.0× 52 0.9× 10 353
Martin Galvan Germany 11 391 1.5× 303 1.7× 37 0.5× 50 0.8× 62 1.0× 14 524
Isaac L. Crawford United States 12 206 0.8× 107 0.6× 105 1.3× 37 0.6× 130 2.2× 16 461
A Kulcsár Hungary 5 243 0.9× 130 0.7× 32 0.4× 28 0.5× 81 1.4× 26 360
Maria Nurmi Finland 7 264 1.0× 206 1.2× 18 0.2× 47 0.8× 42 0.7× 11 354

Countries citing papers authored by B. Esplin

Since Specialization
Citations

This map shows the geographic impact of B. Esplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Esplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Esplin more than expected).

Fields of papers citing papers by B. Esplin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Esplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Esplin. The network helps show where B. Esplin may publish in the future.

Co-authorship network of co-authors of B. Esplin

This figure shows the co-authorship network connecting the top 25 collaborators of B. Esplin. A scholar is included among the top collaborators of B. Esplin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Esplin. B. Esplin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Michael, B. Esplin, & R. Čapek. (2000). Reversal of the activity-dependent suppression of GABA-mediated inhibition in hippocampal slices from γ-vinyl GABA (vigabatrin)-pretreated rats. Neuropharmacology. 39(1). 65–74. 30 indexed citations
2.
Jackson, Michael, B. Esplin, & R. Čapek. (1999). Activity-dependent enhancement of hyperpolarizing and depolarizing γ-aminobutyric acid (GABA) synaptic responses following inhibition of GABA uptake by tiagabine. Epilepsy Research. 37(1). 25–36. 24 indexed citations
3.
Čapek, R. & B. Esplin. (1997). Use-dependent depression of synaptic NMDA receptor mediated responses by dizocilpine (MK-801). Canadian Journal of Physiology and Pharmacology. 75(2). 158–163. 1 indexed citations
4.
Jackson, Michael, Trevor Dennis, B. Esplin, & R. Čapek. (1994). Acute effects of γ-vinyl GABA (vigabatrin) on hippocampal GABAergic inhibition in vitro. Brain Research. 651(1-2). 85–91. 21 indexed citations
5.
Clarke, Paul B. S., Isabelle Chaudieu, H. El‐Bizri, et al.. (1994). The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion. British Journal of Pharmacology. 111(2). 397–405. 62 indexed citations
6.
Čapek, R. & B. Esplin. (1994). Effects of lidocaine on hippocampal pyramidal cells. Neuroreport. 5(6). 681–684. 7 indexed citations
7.
Čapek, R. & B. Esplin. (1993). Frequency-dependent enhancement of hippocampal inhibition by GABA uptake blockers. Epilepsy Research. 16(2). 123–130. 8 indexed citations
8.
Čapek, R. & B. Esplin. (1991). Attenuation of hippocampal inhibition by a NMDA () receptor antagonist. Neuroscience Letters. 129(1). 145–148. 10 indexed citations
9.
Čapek, R. & B. Esplin. (1990). Frequency-dependent effects of GABA uptake blockers on recurrent inhibition in the rat hippocampus. European Journal of Pharmacology. 183(2). 459–460. 1 indexed citations
10.
Bourne, Gerald W., B. Esplin, & R. Čapek. (1988). Disinhibitory effect of phencyclidine in the hippocampus in vitro: PCP receptors implicated. European Journal of Pharmacology. 150(1-2). 67–74. 7 indexed citations
11.
Davies, M. Frances, B. Esplin, & R. Čapek. (1985). The effects of benzodiazepines on spinal homosynaptic depression. Neuropharmacology. 24(4). 301–307. 7 indexed citations
12.
Davies, M. Frances, et al.. (1985). Effects of ammonium chloride on synaptic transmission in the rat hippocampal slice. Neuroscience. 14(3). 799–806. 33 indexed citations
13.
Čapek, R. & B. Esplin. (1982). Baclofen-induced decrease of excitability of primary afferents and depression of monosynaptic transmission in cat spinal cord. Canadian Journal of Physiology and Pharmacology. 60(2). 160–166. 13 indexed citations
14.
Čapek, R. & B. Esplin. (1982). Excitability of primary afferents in feline spinal cord: taurine, homotaurine, and γ-aminobutyric acid compared. Canadian Journal of Physiology and Pharmacology. 60(6). 850–855. 3 indexed citations
15.
Esplin, B.. (1979). Effects of cyclobenzaprine on spinal synaptic transmission. Neuropharmacology. 18(6). 559–564. 9 indexed citations
16.
Esplin, B., et al.. (1979). The anticonvulsant effects of propranolol and β-adrenergic blockade. Cellular and Molecular Life Sciences. 35(1). 80–81. 20 indexed citations
17.
Čapek, R. & B. Esplin. (1977). Effects of ethosuximide on transmission of repetitive impulses and apparent rates of transmitter turnover in the spinal monosynaptic pathway.. Journal of Pharmacology and Experimental Therapeutics. 201(2). 320–325. 9 indexed citations
18.
Čapek, R. & B. Esplin. (1977). Homosynaptic depression and transmitter turnover in spinal monosynaptic pathway. Journal of Neurophysiology. 40(1). 95–105. 37 indexed citations
19.
Esplin, B. & R. Čapek. (1976). Quantitative characterization of THC and ethanol interaction.. PubMed. 15(1). 199–202. 3 indexed citations
20.
Esplin, Don W., R. Čapek, & B. Esplin. (1973). An Intracellular Study of the Actions of Carbon Dioxide on the Spinal Monosynaptic Pathway. Canadian Journal of Physiology and Pharmacology. 51(6). 424–436. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B.S.R. Sastry Breakdown of academic impact, for papers by Peter Dobelis Breakdown of academic impact, for papers by Tsugutaka Ito Breakdown of academic impact, for papers by Sylvester E. Vizi Breakdown of academic impact, for papers by Walter Schlosser Breakdown of academic impact, for papers by Amy DiCamillo Breakdown of academic impact, for papers by Martin Galvan Breakdown of academic impact, for papers by Isaac L. Crawford Breakdown of academic impact, for papers by A Kulcsár Breakdown of academic impact, for papers by Maria Nurmi
Rankless by CCL
2026